Skip to main content
Top
Published in: Sleep and Breathing 3/2020

01-09-2020 | Sleep Apnea | Epidemiology • Original Article

Risk of obstructive sleep apnea in patients with Sjögren syndrome and Behçet’s disease: a nationwide, population-based cohort study

Authors: Tsai-Chu Yeh, Wei-Sheng Chen, Yu-Sheng Chang, Yi-Chun Lin, Yi-Hsiang Huang, Chang-Youh Tsai, Jin-Hua Chen, Chi-Ching Chang

Published in: Sleep and Breathing | Issue 3/2020

Login to get access

Abstract

Purpose

Patients with obstructive sleep apnea (OSA) have a higher risk of Behçet’s disease (BD) and Sjögren syndrome (SS). However, the bidirectional relationship between these autoimmune diseases and OSA is unclear. We investigated the relationship between autoimmune diseases (SS and BD) and OSA.

Methods

SS and BD patients were identified through the Taiwan National Health Insurance Research Database from 2002 to 2012. Patients with SS or BD were matched according to age and sex with a control group in a ratio of 1:4. The study included 12,926 patients with SS and 51,704 non-SS controls. Similarly, 1221 patients with BD were matched with 4884 non-BD controls. We used a Cox regression model, stratified by age, gender, and comorbidities, to assess the risk of OSA.

Results

OSA was diagnosed in 0.61% of the SS cohort and 1.23% of the BD cohort. The higher overall risk for OSA was observed significantly in patients with SS than in controls (adjusted hazard ratio [HR] = 2.48, 95% confidence interval [CI] = 1.89–3.24). The higher risk was also observed significantly in BD patients than in controls (HR = 1.99, 95% CI = 1.06–3.72). Furthermore, men with SS or BD exhibited HR of 2.62 (95% CI 1.89 to 3.62) and 6.40 (95% CI 2.96 to 13.84) for developing OSA, respectively.

Conclusion

Risk of OSA was significantly elevated in SS or BD patients compared with controls. Further study is warranted to elucidate underlying mechanisms.
Literature
1.
go back to reference Pretto JJ, Gyulay SG, Hensley MJ (2010) Trends in anthropometry and severity of sleep-disordered breathing over two decades of diagnostic sleep studies in an Australian adult sleep laboratory. Med J Australia 193:213–216CrossRef Pretto JJ, Gyulay SG, Hensley MJ (2010) Trends in anthropometry and severity of sleep-disordered breathing over two decades of diagnostic sleep studies in an Australian adult sleep laboratory. Med J Australia 193:213–216CrossRef
2.
go back to reference Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O’Connor GT (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6:e1000132CrossRef Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O’Connor GT (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6:e1000132CrossRef
3.
go back to reference Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 283:1829–1836CrossRef Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 283:1829–1836CrossRef
4.
go back to reference Peker Y, Carlson J, Hedner J (2006) Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 28:596–602CrossRef Peker Y, Carlson J, Hedner J (2006) Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 28:596–602CrossRef
5.
go back to reference Punjabi NM, Vsevolod YV (2005) Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99:1998–2007CrossRef Punjabi NM, Vsevolod YV (2005) Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99:1998–2007CrossRef
6.
go back to reference Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3:310–318CrossRef Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3:310–318CrossRef
7.
go back to reference Rose NR (2016) Prediction and prevention of autoimmune disease in the 21st century: a review and preview. Am J Epidemiol 183:403–406CrossRef Rose NR (2016) Prediction and prevention of autoimmune disease in the 21st century: a review and preview. Am J Epidemiol 183:403–406CrossRef
8.
go back to reference Haugen AJ, Peen E, Hulten B, Johannessen AC, Brun JG, Halse AK (2008) Estimation of the prevalence of primary Sjögren’s syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J of Rheumatol 37:30–34CrossRef Haugen AJ, Peen E, Hulten B, Johannessen AC, Brun JG, Halse AK (2008) Estimation of the prevalence of primary Sjögren’s syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J of Rheumatol 37:30–34CrossRef
9.
go back to reference Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sjögren’s syndrome. Autoimmun Rev 9(5):A305–A310CrossRef Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sjögren’s syndrome. Autoimmun Rev 9(5):A305–A310CrossRef
10.
11.
go back to reference Abad VC, Sarinas PS, Guilleminault C (2008) Sleep and rheumatologic disorders. Sleep Med Rev 12:211–228CrossRef Abad VC, Sarinas PS, Guilleminault C (2008) Sleep and rheumatologic disorders. Sleep Med Rev 12:211–228CrossRef
12.
go back to reference Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625–630CrossRef Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625–630CrossRef
13.
go back to reference Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A, Sajid H (2013) Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers--a meta-analysis. J Inflamm (Lond) 10:13CrossRef Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A, Sajid H (2013) Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers--a meta-analysis. J Inflamm (Lond) 10:13CrossRef
14.
go back to reference Kang JH, Lin HC (2012) Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Med 13:583–588CrossRef Kang JH, Lin HC (2012) Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Med 13:583–588CrossRef
15.
go back to reference National Health Insurance. Taiwan public health report 2007. Taipei City: Department of Health, R.O.C.2008 (Taiwan),103. National Health Insurance. Taiwan public health report 2007. Taipei City: Department of Health, R.O.C.2008 (Taiwan),103.
16.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRef
17.
go back to reference International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
18.
go back to reference McNicholas W (2009) Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med 180:692–700CrossRef McNicholas W (2009) Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med 180:692–700CrossRef
19.
go back to reference Hatipoğlu U, Israel R (2004) Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 70:665–671CrossRef Hatipoğlu U, Israel R (2004) Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 70:665–671CrossRef
20.
go back to reference Haensel A, Bardwell WA, Mills PJ, Loredo JS, Ancoli-Israel S, Morgan EE (2009) Relationship between inflammation and cognitive function in obstructive sleep apnea. Sleep Breath 13:35–41CrossRef Haensel A, Bardwell WA, Mills PJ, Loredo JS, Ancoli-Israel S, Morgan EE (2009) Relationship between inflammation and cognitive function in obstructive sleep apnea. Sleep Breath 13:35–41CrossRef
21.
go back to reference Chen WS, Chang YS, Chang CC, Chang DM, Chen YH, Tsai CY, Chen JH (2016) Management and risk reduction of rheumatoid arthritis in individuals with obstructive sleep apnea: a nationwide population-based study in Taiwan. Sleep. 39:1883–1890CrossRef Chen WS, Chang YS, Chang CC, Chang DM, Chen YH, Tsai CY, Chen JH (2016) Management and risk reduction of rheumatoid arthritis in individuals with obstructive sleep apnea: a nationwide population-based study in Taiwan. Sleep. 39:1883–1890CrossRef
22.
go back to reference Karadağ Ö, Nakas D, Kalyoncu U, Akdoğan A, Kiraz S, Ertenli I (2012) Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis. Rheumatol Int 32:1909–1913CrossRef Karadağ Ö, Nakas D, Kalyoncu U, Akdoğan A, Kiraz S, Ertenli I (2012) Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis. Rheumatol Int 32:1909–1913CrossRef
23.
go back to reference Chandrasekhara PK, Jayachandran NV, Rajasekhar L, Thomas J, Narsimulu G (2009) The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol 19:407–415CrossRef Chandrasekhara PK, Jayachandran NV, Rajasekhar L, Thomas J, Narsimulu G (2009) The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol 19:407–415CrossRef
24.
go back to reference Mirrakhimov AE (2013) Obstructive sleep apnea and autoimmune rheumatic disease: is there any link? Inflamm Allergy Drug Targets 12:362–367CrossRef Mirrakhimov AE (2013) Obstructive sleep apnea and autoimmune rheumatic disease: is there any link? Inflamm Allergy Drug Targets 12:362–367CrossRef
25.
go back to reference Kamath J, Galina P, Sarah J (2015) Sleep disturbances in patients with medical conditions. Psych Clin North Am 38:825–841CrossRef Kamath J, Galina P, Sarah J (2015) Sleep disturbances in patients with medical conditions. Psych Clin North Am 38:825–841CrossRef
26.
go back to reference Usmani ZA, Hlavac M, Rischmueller M, Heraganahally SS, Hilditch CJ, Lester S, Catcheside PG (2012) Sleep disordered breathing in patients with primary Sjögren’s syndrome: a group controlled study. Sleep Med 13:1066–1070CrossRef Usmani ZA, Hlavac M, Rischmueller M, Heraganahally SS, Hilditch CJ, Lester S, Catcheside PG (2012) Sleep disordered breathing in patients with primary Sjögren’s syndrome: a group controlled study. Sleep Med 13:1066–1070CrossRef
27.
go back to reference Cai FZ, Lester S, Lu T, Boundy K, Proudman SM, Tonkin A, Rischmueller M (2008) Mild autonomic dysfunction in primary Sjögren’s syndrome: a controlled study. Arthritis Res Ther 10:R31CrossRef Cai FZ, Lester S, Lu T, Boundy K, Proudman SM, Tonkin A, Rischmueller M (2008) Mild autonomic dysfunction in primary Sjögren’s syndrome: a controlled study. Arthritis Res Ther 10:R31CrossRef
28.
go back to reference Gudbjörnsson B, Broman JE, Hetta J, Hällgren R (1993) Sleep disturbances in patients with primary Sjögren’s syndrome. Br J Rheumatol 32:1072–1076CrossRef Gudbjörnsson B, Broman JE, Hetta J, Hällgren R (1993) Sleep disturbances in patients with primary Sjögren’s syndrome. Br J Rheumatol 32:1072–1076CrossRef
29.
go back to reference Oksenberg A, Froom P, Melamed S (2006) Dry mouth upon awakening in obstructive sleep apnea. J Sleep Res 15:317–320CrossRef Oksenberg A, Froom P, Melamed S (2006) Dry mouth upon awakening in obstructive sleep apnea. J Sleep Res 15:317–320CrossRef
30.
go back to reference Tascilar NF, Tekin NS, Ankarali H, Sezer T, Atik L, Emre U, Duysak S, Cinar F (2012) Sleep disorders in Behçet’s disease, and their relationship with fatigue and quality of life. J Sleep Res 21:281–288CrossRef Tascilar NF, Tekin NS, Ankarali H, Sezer T, Atik L, Emre U, Duysak S, Cinar F (2012) Sleep disorders in Behçet’s disease, and their relationship with fatigue and quality of life. J Sleep Res 21:281–288CrossRef
31.
go back to reference Uygunoğlu U, Benbir G, Saip S, Kaynak H, Siva A (2014) A polysomnographic and clinical study of sleep disorders in patients with Behçet and neuro-Behçet syndrome. Eur Neurol 71:115–119CrossRef Uygunoğlu U, Benbir G, Saip S, Kaynak H, Siva A (2014) A polysomnographic and clinical study of sleep disorders in patients with Behçet and neuro-Behçet syndrome. Eur Neurol 71:115–119CrossRef
Metadata
Title
Risk of obstructive sleep apnea in patients with Sjögren syndrome and Behçet’s disease: a nationwide, population-based cohort study
Authors
Tsai-Chu Yeh
Wei-Sheng Chen
Yu-Sheng Chang
Yi-Chun Lin
Yi-Hsiang Huang
Chang-Youh Tsai
Jin-Hua Chen
Chi-Ching Chang
Publication date
01-09-2020
Publisher
Springer International Publishing
Keyword
Sleep Apnea
Published in
Sleep and Breathing / Issue 3/2020
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-019-01953-w

Other articles of this Issue 3/2020

Sleep and Breathing 3/2020 Go to the issue